Search research articles
Contact Us
Filters
Showing results (1-10 of 178) with videos related to
Page
of 18
Sort By:
Viral Immunology
|
November 15, 2014
Immune evasion in ebolavirus infections
Jonathan Audet, Gary P Kobinger
Nature Microbiology
|
August 25, 2017
Viral pathogenesis: Unlocking Ebola persistence
Trina Racine, Gary P Kobinger
Human Vaccines & Immunotherapeutics
|
February 8, 2014
Antibody therapy for Ebola: is the tide turning around?
Xiangguo Qiu, Gary P Kobinger
Clinical Microbiology Reviews
|
May 15, 2015
Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak
Gary Wong, Gary P Kobinger
The Journal of Infectious Diseases
|
November 16, 2013
Retrospective studies: excellent tools to complement surveillance
Xiangguo Qiu, Gary P Kobinger
Human Vaccines & Immunotherapeutics
|
March 21, 2019
Challenges and perspectives on the use of mobile laboratories during outbreaks and their use for vaccine evaluation
Trina Racine, Gary P Kobinger
Expert Review of Vaccines
|
March 25, 2016
Vaccines against 'the other' Ebolavirus species
Robert A Kozak, Gary P Kobinger
Human Vaccines & Immunotherapeutics
|
April 9, 2013
Hypothesis driven development of new adjuvants: short peptides as immunomodulators
Jessica C Dong, Gary P Kobinger
Human Vaccines & Immunotherapeutics
|
December 9, 2014
Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?
Hugues Fausther-Bovendo, Gary P Kobinger
Expert Review of Clinical Immunology
|
April 19, 2014
Characterization of host immune responses in Ebola virus infections
Gary Wong, Gary P Kobinger, Xiangguo Qiu
Page
of 18
Search research articles
Search
Showing results (1-10 of 178) with videos related to
Sort By:
Page
of 18
Viral Immunology
|
November 15, 2014
Immune evasion in ebolavirus infections
Jonathan Audet, Gary P Kobinger
Nature Microbiology
|
August 25, 2017
Viral pathogenesis: Unlocking Ebola persistence
Trina Racine, Gary P Kobinger
Human Vaccines & Immunotherapeutics
|
February 8, 2014
Antibody therapy for Ebola: is the tide turning around?
Xiangguo Qiu, Gary P Kobinger
Clinical Microbiology Reviews
|
May 15, 2015
Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak
Gary Wong, Gary P Kobinger
The Journal of Infectious Diseases
|
November 16, 2013
Retrospective studies: excellent tools to complement surveillance
Xiangguo Qiu, Gary P Kobinger
Human Vaccines & Immunotherapeutics
|
March 21, 2019
Challenges and perspectives on the use of mobile laboratories during outbreaks and their use for vaccine evaluation
Trina Racine, Gary P Kobinger
Expert Review of Vaccines
|
March 25, 2016
Vaccines against 'the other' Ebolavirus species
Robert A Kozak, Gary P Kobinger
Human Vaccines & Immunotherapeutics
|
April 9, 2013
Hypothesis driven development of new adjuvants: short peptides as immunomodulators
Jessica C Dong, Gary P Kobinger
Human Vaccines & Immunotherapeutics
|
December 9, 2014
Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?
Hugues Fausther-Bovendo, Gary P Kobinger
Expert Review of Clinical Immunology
|
April 19, 2014
Characterization of host immune responses in Ebola virus infections
Gary Wong, Gary P Kobinger, Xiangguo Qiu
Page
of 18